Stock options granted to four directors. Total of 3,000 units, 100 shares per unit, granted at no cost, exercise price is the closing price on the allocation date multiplied by 1.025, term of exercisability from 2028\/9\/11 to 2036\/9\/9, maximum dilution 0.47%, allocation date 2026\/9\/10, with details on exercise conditions and handling in case of reorganization.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4599","jir_company_name":"Stemrim Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-09-09","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/09\/4599-20260909-02.pdf","jir_short_summary":"Stock options granted to four directors. Total of 3,000 units, 100 shares per unit, granted at no cost, exercise price is the closing price on the allocation date multiplied by 1.025, term of exercisability from 2028\/9\/11 to 2036\/9\/9, maximum dilution 0.47%, allocation date 2026\/9\/10, with details on exercise conditions and handling in case of reorganization.","jir_summary":"### Section Heading\nThis matter reports that resolutions were made to issue stock options to four directors of our company (including outside directors). Grants are free of charge, with 100 shares per unit and a total of 3,000 units. The exercise price is the allocation-day closing price multiplied by 1.025, with adjustment provisions for stock splits and reverse splits and provisions for adjustments at the time of equity issuance. The exercise period is from 2028\/9\/11 to 2036\/9\/9. The maximum dilution is expected to be 0.47%.\n\n### Section 2 Heading\nThe conditions for acquiring the stock options, transfer restrictions, handling during corporate reorganizations, acquisition grounds, and other exercise conditions and post-reorganization treatment are detailed. Regarding impact on shareholders, it is deemed within a reasonable range, and since the consideration is free, there will be no capital increase. The future impact on shareholder value will be evaluated as an emergent talent incentive design.","jir_financial_highlights":"Number of stock options issued: 3,000 units (Unknown)\nNumber of shares issued per unit: 100 shares per unit, total 300,000 shares (Unknown)\nMaximum dilution: 0.47\uff05 (Unknown)\nExercise price calculation: Allocation date closing price \u00d7 1.025, rounding up fractions (Unknown)\nExercise period: September 11, 2028 \u2013 September 9, 2036 (Unknown)","jir_category":"","jir_hashtags":"","jir_key_figures":"Number of stock options issued: 3,000 units\nShares granted: 300,000 shares (100 shares per unit)\nMaximum dilution: 0.47%\nExercise price: Allocation date closing price \u00d7 1.025, rounding up to the nearest yen\nExercise period: September 11, 2028 \u2013 September 9, 2036","jir_meta_title":"Stemrim Co., Ltd. \u2013 Resolution to Issue Stock Options to 4 Directors | 3,000 units issued, maximum dilution 0.47%","jir_meta_description":"Stemrim resolves to grant stock options to four directors at no cost. Total of 3,000 units, 100 shares per unit, exercise price = allocation day closing price \u00d7 1.025, exercise period from 2028 to 2036. Maximum dilution planned at 0.47%.","jir_og_title":"Resolution to Issue Stock Options","jir_og_description":"Stemrim grants stock options to four directors at no cost. Maximum dilution up to 0.47%, exercise period 2028\u20132036.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":58113,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"stock_option","footnotes":""},"sector":[],"importance":[],"class_list":["post-111856","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n